Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers-Reference-Cited by-同舟云学术

Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers

Published:1986 Issue:S1 Volume:31 Page:9-14
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Lambe R.,Kennedy O.,Kenny M.,Darragh A.,Dodion L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00541461.pdf

Reference9 articles.

1. Lesne M, Clerckx-Braun F, Duhoux P, van Ypersele de Strihoux Ch (1982) Pharmacokinetic study of torasemide in humans: An overview of its diuretic effect. Int J Clin Pharmacol Ther Toxicol 20 [8]: 382?397

2. Hutcheon DE, Genevieve L (1967) Diuretic and antihypertensive actions of furosemide. J Clin Pharmacol 7: 26?33

3. Olesen JH, Sigurd B, Steiness E, Leth A (1973) Bumetanide, a new potent diuretic. Acta Med Scand 193: 119?131

4. Steele TH, Oppenheimer S (1969) Factors affecting urate excretion following diuretic administration in man. Am J Med 47: 564?574

5. Roberts CJC, Homeida M, Roberts F (1978) Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects. Br J Clin Pharmacol 6: 129?133

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evaluation of torsemide in patients with heart failure and renal disease;Expert Review of Cardiovascular Therapy;2022-01-03

2. Loop Diuretics in the Treatment of Hypertension;Current Hypertension Reports;2016-03-07

3. Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure;Drug Design, Development and Therapy;2015-08

4. A BIOAVAILABILITY/BIOEQUIVALENCE AND PHARMACOKINETIC STUDY OF TWO ORAL DOSES OF TORASEMIDE (5 AND 10 mg): PROLONGED-RELEASE VERSUS THE CONVENTIONAL FORMULATION;Clinical and Experimental Pharmacology and Physiology;2009-05

5. Diuretic and Uricosuric Agents;Burger's Medicinal Chemistry and Drug Discovery;2003-01-15